NO976143D0 - Anvendelse av minst en <beta>-adrenergisk agonist som en P substans antagonist - Google Patents

Anvendelse av minst en <beta>-adrenergisk agonist som en P substans antagonist

Info

Publication number: NO976143D0
Authority: NO; Norway
Prior art keywords: beta; adrenergic agonist; substance antagonist; antagonist; substance
Prior art date: 1995-10-23

Application number

NO976143A

Other languages

English (en)

Other versions

NO312273B1 (no

NO976143L (no

Inventor

Lionel Breton

Olivier De Lacharriere

Jacques Leclaire

Original Assignee

Oreal

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-10-23

Filing date

1997-12-30

Publication date

1997-12-30

1997-12-30 Application filed by Oreal filed Critical Oreal

1997-12-30 Publication of NO976143D0 publication Critical patent/NO976143D0/no

1998-06-03 Publication of NO976143L publication Critical patent/NO976143L/no

2002-04-22 Publication of NO312273B1 publication Critical patent/NO312273B1/no

Links

239000000048 adrenergic agonist Substances 0.000 title 1
239000005557 antagonist Substances 0.000 title 1
ADNPLDHMAVUMIW-CUZNLEPHSA-N substance P Chemical compound C([C@@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(N)=O)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](N)CCCN=C(N)N)C1=CC=CC=C1 ADNPLDHMAVUMIW-CUZNLEPHSA-N 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/41—Amines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/02—Preparations for cleaning the hair
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/75—Anti-irritant

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Dermatology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
Epidemiology (AREA)
Emergency Medicine (AREA)
Birds (AREA)
Toxicology (AREA)
Cosmetics (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)

NO19976143A 1995-10-23 1997-12-30 Anvendelse av minst en <beta>-adrenergisk agonist som en substans P antagonist NO312273B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR9512447A FR2740040B1 (fr)	1995-10-23	1995-10-23	Utilisation d'au moins un agoniste beta-adrenergique en tant qu'antagoniste de substance p
PCT/FR1996/001530 WO1997015281A1 (fr)	1995-10-23	1996-10-01	Utilisation d'au moins un agoniste beta-adrenergique en tant qu'antagoniste de substance p

Publications (3)

Publication Number	Publication Date
NO976143D0 true NO976143D0 (no)	1997-12-30
NO976143L NO976143L (no)	1998-06-03
NO312273B1 NO312273B1 (no)	2002-04-22

Family

ID=9483809

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO19976143A NO312273B1 (no)	1995-10-23	1997-12-30	Anvendelse av minst en <beta>-adrenergisk agonist som en substans P antagonist

Country Status (14)

Country	Link
US (2)	US5958432A (no)
EP (1)	EP0769293B1 (no)
JP (1)	JP3636473B2 (no)
AR (1)	AR004052A1 (no)
BR (1)	BR9611302A (no)
CA (1)	CA2222311C (no)
DE (1)	DE69603681T2 (no)
DK (1)	DK0769293T3 (no)
FR (1)	FR2740040B1 (no)
HU (1)	HUP9900511A3 (no)
NO (1)	NO312273B1 (no)
PL (1)	PL186366B1 (no)
RU (1)	RU2169552C2 (no)
WO (1)	WO1997015281A1 (no)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5948972A (en) *	1994-12-22	1999-09-07	Kla-Tencor Corporation	Dual stage instrument for scanning a specimen
WO2002007682A1 (en) *	2000-07-26	2002-01-31	Vyden John K	Methods for treating atopic disorders
ITPD20010187A1 (it) *	2001-07-23	2003-01-23	Cutech Srl	Trattamento del follicolo polifero, in particolare contro la caduta dei capelli
EP1295599A1 (en) *	2001-09-21	2003-03-26	Boehringer Ingelheim International GmbH	Method for the treatment of prevention of atopic dermatitis
US20030219573A1 (en) *	2002-03-27	2003-11-27	Torgny Falk	Absorbent product
US7345065B2 (en) *	2002-05-21	2008-03-18	Allergan, Inc.	Methods and compositions for alleviating pain
RU2220738C1 (ru) *	2002-08-30	2004-01-10	Гапонюк Петр Яковлевич	Средство для лечения ринита
US8343519B2 (en) *	2003-02-19	2013-01-01	L'oreal S.A.	Chemical enhancer and method
EP1613266A4 (en) *	2003-04-15	2009-05-06	Theraquest Biosciences Llc	METHOD FOR TREATING PAIN AND COMPOSITIONS FOR USE THEREOF
CA2589001A1 (en) *	2004-11-19	2006-05-26	Kissei Pharmaceutical Co., Ltd.	Preventive or therapeutic agent for neuropathic pain
US8426475B2 (en) *	2005-04-13	2013-04-23	Astion Development A/S	Treatment of connective tissue diseases of the skin
CA2715110A1 (fr) *	2008-01-18	2009-09-17	Centre National De La Recherche Scientifique (Cnrs)	Composes utilisables pour le traitement de douleurs neuropathiques
GB0805535D0 (en) *	2008-03-27	2008-04-30	Univ Leicester	Scar prevention
US8420114B2 (en) *	2008-04-18	2013-04-16	Warsaw Orthopedic, Inc.	Alpha and beta adrenergic receptor agonists for treatment of pain and / or inflammation
EA201101207A1 (ru) *	2009-02-24	2012-04-30	Новартис Аг	Применение антагонистов рецептора nk
GB2513297A (en)	2013-03-08	2014-10-29	Univ Leicester	Methods
EP3319607A4 (en)	2015-07-09	2019-04-03	Galderma S.A.	METHOD FOR REDUCING HAIR LOSS IN CONNECTION WITH CHEMOTHERAPY
JP7152051B2 (ja) *	2018-05-29	2022-10-12	株式会社ナノエッグ	アトピー性皮膚炎を治療または予防するための組成物
AU2019336248A1 (en) *	2018-09-08	2021-05-13	Tan WEN	New use of R-enantiomer of adrenergic β2 receptor agonists for treatment of inflammatory bowel disease and its extra intestinal manifestations

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1474316A (en) *	1975-02-12	1977-05-25	Seperic	O-aminoalkyl oximes
US4038417A (en) *	1975-06-19	1977-07-26	Nelson Research & Development Company	Method for treatment of psoriasis
US4525359A (en) *	1982-12-10	1985-06-25	Greenway Frank L Iii	Treatment for selective weight control
US5366731A (en) *	1990-08-24	1994-11-22	Wisconsin Alumni Research Foundation	Cosmetic compositions containing secosterol compounds
IL99368A (en) *	1991-09-02	1996-01-19	Teva Pharma	Preparations for the treatment of psoriasis and atopic dermatitis, which contain the result of xanthine
CA2114968A1 (en) *	1993-02-25	1994-08-26	John Wille	Transdermal treatment with mast cell degranulating agents for drug-induced hypersensitivity
JPH07258067A (ja) *	1994-03-18	1995-10-09	Kao Corp	浴用剤組成物
FR2719474B1 (fr) *	1994-05-05	1996-05-31	Oreal	Utilisation d'un antagoniste de substance P dans une composition cosmétique et composition obtenue.

1995
- 1995-10-23 FR FR9512447A patent/FR2740040B1/fr not_active Expired - Fee Related
1996
- 1996-10-01 RU RU97121883/14A patent/RU2169552C2/ru not_active IP Right Cessation
- 1996-10-01 JP JP51633197A patent/JP3636473B2/ja not_active Expired - Fee Related
- 1996-10-01 PL PL96324924A patent/PL186366B1/pl not_active IP Right Cessation
- 1996-10-01 WO PCT/FR1996/001530 patent/WO1997015281A1/fr not_active Ceased
- 1996-10-01 DE DE69603681T patent/DE69603681T2/de not_active Expired - Fee Related
- 1996-10-01 HU HU9900511A patent/HUP9900511A3/hu unknown
- 1996-10-01 DK DK96402098T patent/DK0769293T3/da active
- 1996-10-01 EP EP96402098A patent/EP0769293B1/fr not_active Expired - Lifetime
- 1996-10-01 CA CA002222311A patent/CA2222311C/fr not_active Expired - Fee Related
- 1996-10-01 BR BR9611302A patent/BR9611302A/pt not_active IP Right Cessation
- 1996-10-21 AR ARP960104829A patent/AR004052A1/es not_active Application Discontinuation
- 1996-10-23 US US08/731,967 patent/US5958432A/en not_active Expired - Fee Related
1997
- 1997-12-30 NO NO19976143A patent/NO312273B1/no unknown
1999
- 1999-05-12 US US09/310,099 patent/US6267972B1/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
FR2740040A1 (fr)	1997-04-25
FR2740040B1 (fr)	1997-12-05
JP3636473B2 (ja)	2005-04-06
US5958432A (en)	1999-09-28
CA2222311C (fr)	2006-11-28
WO1997015281A1 (fr)	1997-05-01
RU2169552C2 (ru)	2001-06-27
MX9710475A (es)	1998-08-30
HUP9900511A2 (hu)	1999-07-28
US6267972B1 (en)	2001-07-31
DE69603681D1 (de)	1999-09-16
EP0769293A3 (fr)	1997-05-02
PL324924A1 (en)	1998-06-22
NO312273B1 (no)	2002-04-22
CA2222311A1 (fr)	1997-05-01
EP0769293A2 (fr)	1997-04-23
DK0769293T3 (da)	1999-12-06
EP0769293B1 (fr)	1999-08-11
DE69603681T2 (de)	1999-11-25
AR004052A1 (es)	1998-09-30
PL186366B1 (pl)	2003-12-31
HUP9900511A3 (en)	2000-09-28
BR9611302A (pt)	1999-03-30
NO976143L (no)	1998-06-03
JP2000503628A (ja)	2000-03-28

Publication	Publication Date	Title
NO976143D0 (no)	1997-12-30	Anvendelse av minst en <beta>-adrenergisk agonist som en P substans antagonist
FI964576A7 (fi)	1996-11-15	Uusia agonistiyhdisteitä
NO960081D0 (no)	1996-01-08	Östrogen-agonist/antagonister
FI972970A7 (fi)	1997-09-11	Uusia yhdisteitä
NO20010603D0 (no)	2001-02-05	2-substituert-1-piperidylbenzimidazol forbindelser som ORL 1- reseptor agonister
DE69800895D1 (de)	2001-07-19	Interleukin-1 Rezeptor Antagonist beta (il-1rabeta)
FI20030370L (fi)	2003-03-12	Uusia yhdisteitä
DK0861235T3 (da)	2001-12-27	Substituerede benzylaminopiperidinforbindelser
LU90115B1 (fr)	1997-09-10	Formulation orale de 2-méthyl-thiéno-benzodiazépine
FI960399A7 (fi)	1996-01-29	Perhydroisoindolijohdannaisia P-aineen antagonisteina
DK0722736T3 (da)	2001-04-02	Topisk sammensætning indeholdende en antagonist for substans P
DK0820451T3 (da)	2003-05-12	Hidtil ukendte heterocykliske forbindelser
BR9505382A (pt)	1997-10-28	Utilização de ao menos um antagonista de substáncia P
DK0854867T3 (da)	2002-12-02	Tetrahydroquinoliner som NMDA-antagonister
DK0747346T3 (da)	2000-06-05	N-acyl-2-arylcyclopropylmethylaminderivater som melatonerge midler
ITMI950098A0 (it)	1995-01-23	Procedimento per la preparazione di composti metallocenici
NO20002439L (no)	2000-05-11	Nye orale doseringsformer for carvediol
NO970372D0 (no)	1997-01-28	Aroyloksy- og aroyltiopropanolamin-derivater anvendelige som <beta>-3-adrenoreseptor-agonister og antagonister for <beta>-1-og-<beta>-2-adrenoreseptorer og farmasöytiske blandinger derav
FI951798A0 (fi)	1995-04-13	Bentsofuraanijohdannaiset 5-HT1-kaltaisina reseptoriantagonisteina
IS4597A (is)	1997-10-22	Ný lyfjafræðileg notkun AII-viðtaka mótlyfja
BR9505392A (pt)	1997-10-28	Utilizações de ao menos um antagonista de substância P
FR2732894B1 (fr)	1997-07-04	Nouvelle utilisation de composes agonistes beta9-adrenergiques
FR2734482B1 (fr)	1997-08-14	Nouvelle utilisation de composes agonistes beta3-adrenergiques
DK0938330T3 (da)	2002-05-27	Anvendelse af LH-RH antagonister som diagnostisk middel
BR9502589A (pt)	1997-08-26	Adaptador tubular